Unlock instant, AI-driven research and patent intelligence for your innovation.

RAGE antagonistic polypeptide and application thereof

An antagonistic and derivative technology, applied in the field of biotechnology and biomedicine, can solve the problems of reduced action time and easy degradation of siRNA by the body, and achieves huge social and economic benefits.

Active Publication Date: 2019-10-11
SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, siRNA therapy has obvious disadvantages, that is, siRNA is easily degraded by the body when it enters the human body, resulting in a greatly reduced action time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • RAGE antagonistic polypeptide and application thereof
  • RAGE antagonistic polypeptide and application thereof
  • RAGE antagonistic polypeptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Example 1 QPCR detection of RAGE protein expression levels in different cancer cells

[0039] Take normal breast cells MCF-10A, estrogen positive (ER+) cells MCF-7 and triple negative cells MDA-MB-231 cells.

[0040]RNA extraction: Take a 6cm petri dish as an example. When the cells grow well and the confluence reaches 80-90%, discard the cell culture medium and add 1×PBS to wash the cells to remove the remaining culture medium. Then add 300-500 μL of Trizol (the amount of Trizol is determined according to the cell density) into a 6 cm petri dish, and use a pipette to blow repeatedly until the cells are broken and there is no obvious precipitation in the lysate. Put it in a 1.5mL EP tube (note the use of RNase-free pipette tips and EP tubes, and it is best to wear a mask); place it on ice for 5 minutes, then add chloroform at a ratio of Trizol to chloroform of 5:1, Vigorously shake for 15s, chloroform can effectively separate the organic phase from the inorganic phase,...

Embodiment 2

[0050] Example 2 Screening, Synthesis and Identification of RAGE Antagonistic Polypeptides

[0051] 1. Screening of RAGE antagonistic polypeptides

[0052] (1) Establishment of 293T cell line with permanent high expression of RAGE: 293T-RAGE + / + / LRH

[0053] ①Select vigorously growing human-derived 293T cells, and the day before transfection, use 5×10 5 cells / well, seeded in a 6-well plate, cultured until the second day, the cell confluency was 60%;

[0054] ②Transfection was carried out on the second day, using one culture well of a 6-well plate as a unit, dilute 3 μg RAGE expression plasmid with 200 μL opti-MEM medium, and dilute 6 μL liposome Lipofectamine2000 with 200 μL opti-MEM medium, respectively After mixing gently, let stand at room temperature for 5 minutes;

[0055] ③ Gently mix the two tubes of dilutions, let stand at room temperature for 20 minutes, then gently add 600 μL of opti-MEM medium to the mixed dilutions;

[0056] ④ Gently rinse the cells to be tra...

Embodiment 3

[0083] The specific binding of RAGE antagonistic polypeptide to RAGE

[0084] FITC-labeled RAGE antagonistic polypeptides (Shanghai Qiangyao Biological Co., Ltd.), inoculated MDA-MB-231 cells on confocal plates, washed three times with PBS, fixed with paraformaldehyde for 15 minutes, washed three times with PBS, blocked with BSA for 1.5 hours, and incubated RAGE antibody overnight, using Alexa 594-linked anti-rabbit fluorescent secondary antibody was incubated at room temperature for 1 hour, and then incubated with FITC-labeled RAGE antagonistic polypeptide at a final concentration of 100 μmol / mL for 2 hours at room temperature, washed three times with PBST, stained with DAPI, and confocal laser scanning microscope (German Zeiss Co., Ltd. ) observation, see the results Figure 4 .

[0085] in, Figure 4 A is the fluorescent confocal microscope image of DAPI nuclear staining (shown in blue in the original fluorescent color map);

[0086] Figure 4 B after incubation of MD...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biotechnology and biomedicine and particularly relates to an RAGE antagonistic polypeptide and application thereof. The RAGE antagonistic polypeptide obtained after screening with RAGE as a target can be specifically combined with the RAGE through a phage display technology, a signal path of the RAGE is blocked, proliferation of cancer cells is thus inhibited,and an effective micromolecular medicament is provided for RAGE-mediated cancer; the RAGE antagonistic polypeptide can be widely applied to the fields of medicine and biology.

Description

technical field [0001] The invention belongs to the fields of biotechnology and biomedicine, and specifically relates to a RAGE antagonistic polypeptide and its application. Background technique [0002] Breast cancer refers to malignant tumors that occur in the glandular epithelial tissue of the breast. 4% to 6% of breast cancers are metastatic breast cancer when they are diagnosed, and 30% to 40% of early stage patients who receive adjuvant therapy can develop into metastatic breast cancer, and the 5-year survival rate of patients is about 20%. However, traditional treatment methods such as surgery, radiotherapy, and chemotherapy have poor specificity and specificity, and will inevitably have a lethal effect on normal cells and tissues, bringing great side effects to patients. Therefore, finding efficient and specific targeted drugs will greatly improve the therapeutic effect of breast cancer. [0003] Molecular targeted therapy of breast cancer refers to the treatment o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/06C12N15/11C12N15/70C12N1/21A61K38/08A61P35/00C12R1/19
CPCA61K38/00A61P35/00C07K7/06C12N15/70
Inventor 黄来强代小勇蒋盛威刘可为邓婷王丽君
Owner SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV